Cure unwanted? Exploring the chronic Lyme disease controversy and why conflicts of interest in practice guidelines may be guiding us down the wrong path. 2012 https://litigation-essentials.lexisnexis.com/webcd/app?action=DocumentDisplay&crawlid=1&doctype=cite&docid=38+Am.+J.+L.+and+Med.+196&srctype=smi&srcid=3B15&key=f63d469bade6fb7f08df82f6d1173157 American Journal of Law & Medicine 38 Am. J. L. and Med. 196 AuthorJohanna Ferguson Excerpt Patients and physicians were startled to learn of the pervasive conflicts of interest that came to play in the promulgation of the IDSA guidelines regarding chronic Lyme disease. As Pamela Weintraub noted in her book, Cure Unknown, the very people who wrote the IDSA guidelines were those who stood to profit from them. The authors of the guidelines not only had significant connections to drug companies, related patents, and Lyme diagnostic tests, several were also being paid by insurance companies to corroborate treatment plans .. More....